BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21946174)

  • 1. Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange.
    Uchiyama H; Mano Y; Taketomi A; Soejima Y; Yoshizumi T; Ikegami T; Shirabe K; Maehara Y
    Transplantation; 2011 Nov; 92(10):1134-9. PubMed ID: 21946174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
    Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
    Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
    Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.
    Lee SD; Kim SH; Kong SY; Kim YK; Park SJ
    Transpl Immunol; 2015 Jan; 32(1):29-34. PubMed ID: 25449537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
    Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
    Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
    Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
    Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
    Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.
    Kim JM; Kwon CH; Joh JW; Kang ES; Park JB; Lee JH; Kim SJ; Paik SW; Lee SK; Kim DW
    J Hepatol; 2013 Dec; 59(6):1215-22. PubMed ID: 23928408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Kwon SW; Ko GY; Kim KW
    Liver Transpl; 2010 Apr; 16(4):491-8. PubMed ID: 20222051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation.
    Kanazawa H; Fukuda A; Mali VP; Rahayatri TH; Hirata Y; Sasaki K; Uchida H; Shigeta T; Sakamoto S; Matsumoto K; Kasahara M
    Pediatr Transplant; 2016 May; 20(3):401-7. PubMed ID: 27012966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.
    Iso Y; Sawada T; Kita J; Shiraki T; Sakuraoka Y; Kato M; Shimoda M; Kubota K
    Hepatogastroenterology; 2013 Oct; 60(127):1624-6. PubMed ID: 24634932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients.
    Hwang S; Lee SG; Moon DB; Song GW; Ahn CS; Kim KH; Ha TY; Jung DH; Kim KW; Choi NK; Park GC; Yu YD; Choi YI; Park PJ; Ha HS
    Liver Transpl; 2010 Apr; 16(4):482-90. PubMed ID: 20222052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.
    Lee SD; Kim SH; Kong SY; Kim YK; Lee SA; Park SJ
    HPB (Oxford); 2014 Sep; 16(9):807-13. PubMed ID: 24467804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
    Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.